J. E. Staples, M. Gershman, and M. Fischer, Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep, vol.59, issue.7, pp.1-27, 2010.

T. P. Monath and P. Vasconcelos, Yellow fever, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.64, pp.160-73, 2015.

M. Theiler and H. H. Smith, The use of yellow fever virus modified by in vitro cultivation for human immunization, J Exp Med, vol.65, issue.6, pp.787-800, 1937.

T. P. Monath, Yellow fever vaccine, Expert Rev Vaccines, vol.4, issue.4, pp.553-74, 2005.

C. Escadafal, Rapid molecular assays for the detection of yellow fever virus in low-resource settings, PLoS Negl Trop Dis, vol.8, issue.3, p.2730, 2014.

N. P. Lindsey, I. B. Rabe, E. R. Miller, M. Fischer, and J. E. Staples, Adverse event reports following yellow fever vaccination, J Travel Med, vol.23, issue.5, pp.2007-2020, 2016.

A. W. Mcmahon, Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases, Vaccine, vol.25, issue.10, pp.1727-1761, 2007.

M. D. Gershman, Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data, Vaccine, vol.30, issue.33, pp.5038-58, 2012.

T. P. Monath, Suspected yellow fever vaccine-associated Viscerotropic adverse events (1973 and 1978), United States, Am J Trop Med Hyg, vol.82, issue.5, pp.919-940, 2010.

R. Galler, Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil, Virology, vol.290, issue.2, pp.309-328, 2001.

H. Bae, Immune response during adverse events after 17D-derived yellow fever vaccination in Europe, J Infect Dis, vol.197, issue.11, pp.1577-84, 2008.

P. F. Vasconcelos, Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases, Lancet, vol.358, issue.9276, pp.91-98, 2001.

M. Martin, Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases, Lancet Lond Engl, vol.358, issue.9276, pp.98-104, 2001.

R. W. Douce, D. Freire, B. Tello, and G. A. Vásquez, A case of yellow fever vaccineassociated Viscerotropic disease in Ecuador, Am J Trop Med Hyg, vol.82, issue.4, pp.740-742, 2010.

J. Muñoz, Yellow fever-associated Viscerotropic disease in Barcelona, Spain, J Travel Med, vol.15, issue.3, pp.202-207, 2008.

C. Domingo, Detection of yellow fever 17D genome in urine, J Clin Microbiol, vol.49, issue.2, pp.760-762, 2011.

A. L. Biancardi and H. V. De-moraes, Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports, Ocul Immunol Inflamm, pp.1-3, 2018.

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations